FEMY vs NDAQ · rev $756.7K vs P/E 41, rev $2.53B
Femasys Inc (FEMY) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Femasys Inc (FEMY) is a medical instruments & supplies company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported FEMY revenue for 2026-06-30 was $756.7K. Net income was -$3.6M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. FEMY currently screens at market cap $925.2K.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
FEMY currently screens at market cap $925.2K. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the FEMY and NDAQ stock pages for the full models.
Not investment advice.